683 Capital Management »

Immuneering Corp - Class A shares owned by 683 Capital Management

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $992k 151k 6.58

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Immuneering Corp - Class A

FMR
Sanofi
Empery Asset Management
Vanguard Group
State Street Corporation
BlackRock
Citadel Advisors
Marshall Wace
Blue Owl Capital Holdings
Geode Capital Management
Goldman Sachs Group
Burkehill Global Management
Southport Management
Diametric Capital
Millennium Management

View all funds holding Immuneering Corp - Class A